Regenerative devices is an emerging technology area with huge market potential. It belongs within the area of regenerative medicine, identified by the Government as one of eight ‘great technologies’ in which the UK has the potential to be a global leader.
The Medical Technologies IKC is focusing on the regenerative devices sector because of the potential to commercialise technologies more quickly and cost effectively. Our experts are able to take a strategic approach to selecting the right technologies to invest in – identifying cost effective healthcare interventions with shorter translation pathways and lower development costs. It takes, typically, fewer than 10 years to translate regenerative devices into the market place and costs less than £10m – much less than all other forms of regenerative and cell therapies.
Company’s Keywords:
<7
<
<2007
Your request has been submitted successfully.
Own or work here?